SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-029087
Filing Date
2016-11-14
Accepted
2016-11-14 07:04:11
Documents
45
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q reta-10q_20160930.htm 10-Q 1327161
2 EX-10.1 reta-ex101_619.htm EX-10.1 125779
3 EX-10.2 reta-ex102_352.htm EX-10.2 162375
4 EX-10.3 reta-ex103_350.htm EX-10.3 193598
5 EX-10.4 reta-ex104_349.htm EX-10.4 203236
6 EX-31.1 reta-ex311_6.htm EX-31.1 19038
7 EX-31.2 reta-ex312_8.htm EX-31.2 18961
8 EX-32.1 reta-ex321_7.htm EX-32.1 10264
9 EX-32.2 reta-ex322_9.htm EX-32.2 10249
10 GRAPHIC g201611131701200621994.jpg GRAPHIC 14991
11 GRAPHIC g201611131701212531995.jpg GRAPHIC 15641
12 GRAPHIC g201611131701198731993.jpg GRAPHIC 31872
  Complete submission text file 0001564590-16-029087.txt   3779569

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE DOCUMENT reta-20160930.xml EX-101.INS 384677
14 XBRL TAXONOMY EXTENSION SCHEMA reta-20160930.xsd EX-101.SCH 18727
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20160930_cal.xml EX-101.CAL 28486
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20160930_def.xml EX-101.DEF 52146
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20160930_lab.xml EX-101.LAB 162987
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20160930_pre.xml EX-101.PRE 123448
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 161990402
SIC: 2834 Pharmaceutical Preparations